Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MaxCyte (MXCT) Regulatory News

Date Source Headline
12th Jul 2022 7:00 am RNS Grant of Options
8th Jul 2022 5:16 pm RNS Holding(s) in Company
1st Jul 2022 7:00 am RNS Total Voting Rights
30th Jun 2022 7:00 am RNS Result of AGM
17th Jun 2022 2:51 pm RNS Holdings in Company
6th Jun 2022 7:00 am RNS Publication of Annual Report
27th May 2022 7:00 am RNS Notice of AGM
16th May 2022 7:00 am RNS Inducement Grants
10th May 2022 7:00 am RNS Filing of Form 10-Q
10th May 2022 7:00 am RNS MaxCyte Reports First Quarter Financial Results
4th May 2022 7:00 am RNS Upcoming Investor Conferences
29th Apr 2022 2:41 pm RNS Total Voting Rights
19th Apr 2022 7:00 am RNS Inducement Grants Under Nasdaq Listing Rule 5635
13th Apr 2022 7:00 am RNS Departure of CFO and Preliminary Q1 2022 Revenue
11th Apr 2022 7:00 am RNS Holding(s) in Company
1st Apr 2022 7:02 am RNS Total Voting Rights
28th Mar 2022 1:19 pm RNS Grant of Options and PDMR Dealing
28th Mar 2022 7:00 am RNS Grant of Options and PDMR Dealing
23rd Mar 2022 7:00 am RNS Fourth Quarter and Full Year Financial Results
10th Mar 2022 7:00 am RNS MaxCyte, Names Cenk Sumen Chief Scientific Officer
8th Mar 2022 2:29 pm RNS Holding(s) in Company
3rd Mar 2022 9:45 am RNS Holding(s) in Company
1st Mar 2022 7:00 am RNS Block Listing Return
24th Feb 2022 1:00 pm RNS Notice of Results
22nd Feb 2022 3:56 pm RNS Holding(s) in Company
21st Feb 2022 7:00 am RNS Consolidation of Trading Lines
14th Feb 2022 1:00 pm RNS Upcoming Investor Conferences
14th Feb 2022 7:00 am RNS Inducement Grants Under Nasdaq Listing Rule
1st Feb 2022 7:00 am RNS License with Intima Bioscience
24th Jan 2022 7:30 am RNS Preliminary Unaudited Q4 & FY 2021 Revenue Results
29th Dec 2021 3:30 pm RNS Holdings in Company
1st Dec 2021 5:00 pm RNS Total Voting Rights
23rd Nov 2021 7:32 am RNS Purchase of Common Stock
17th Nov 2021 5:36 pm RNS Exercise of options and PDMR Dealing
11th Nov 2021 7:00 am RNS MaxCyte Reports Third Quarter Financial Results
3rd Nov 2021 1:00 pm RNS Appointment of Chairman of the Board
29th Oct 2021 5:01 pm RNS Result of AGM
28th Oct 2021 3:00 pm RNS License with Nkarta, Inc.
26th Oct 2021 7:00 am RNS Notice of Results
6th Oct 2021 7:00 am RNS Holdings in Company
FTSE 100 Latest
Value8,275.66
Change0.00